Biopharmaceutical company developing therapeutics for rare neurological childhood diseases

Biopharmaceutical company developing microbiome technologies and microbiome-based health supplements

• Research and product development leadership to meet short/long-term the business objectives• Lead innovative product concepts from the microbiome discovery platform• Strategize the product drug pipeline for various diseases and indications from discovery platform• Strategize and lead the identification and characterization of active molecules from complex biologics • Presenting research and technologies plan and strategies to executive management• Develop and lead the preclinical studies on the pipe-line biologics from microbiome discovery platform• Worked with regulatory experts to get approval for 510k medical device premarket approval• Responsible for identifying and developing innovation capabilities and partnership opportunities• Identified strategic partners for key technology and product development areas• Manage and help develop capabilities and career of high-level research staffs (PhD’s, Masters-level)

• Lead new technology development assessment/application process to identify and develop innovative antimicrobial technologies that align with business needs• Technology pipe-line development for antimicrobial products• Lead new product research and develop its commercial applied aspects by working with the business development managers• Testing existing products using ASTM and EPA approved efficiency testing• Filing environmental compliance and safety documents for MIOX • Act as Biosafety Officer and work closely with General Safety and Quality Assurance Division

• Technology consulting for due diligence for new product development in advanced biofuel sector• Develop business plan and research and development structure for biofuel and biochemical sector• Algae product market trends and algae techno-economic analysis

• Studying the role of neuroserpin, tissue plasminogen activator and thyroid hormone in Alzheimer’s disease progression in mouse models.

• Developing productive interactions with scientists and engineers to facilitate patenting process• Initial invention disclosure and patents analysis for non-obviousness, utility and inventiveness• Conduct patent landscape studies and to bundle key universities patents and technologies to transform into viable start-up ventures • Drafting business plans and market analysis for start-up companies for STC, UNM

• Develop antimicrobial peptide combinations against infectious disease agents • T-cell positive selection studies to study the effect of procainamide in inducing auto-immunity

• Study the growth and immune parameters of fish-fed with ratio of n-3/n-6 fatty acid sources